US Stock MarketDetailed Quotes

Sensei Biotherapeutics (SNSE)

Watchlist
  • 28.700
  • -1.450-4.81%
Close Apr 14 16:00 ET
  • 28.700
  • 0.0000.00%
Post 20:01 ET
38.47MMarket Cap-1.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sensei Biotherapeutics (SNSE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.61%22.29M
-32.31%4.96M
-37.99%4.85M
-33.14%5.21M
-16.68%7.27M
-14.57%31.66M
-10.06%7.32M
1.11%7.82M
-23.48%7.79M
-20.69%8.73M
Selling and administrative expenses
-13.10%11.33M
-1.52%2.79M
-27.34%2.32M
-16.55%2.67M
-6.92%3.55M
-30.53%13.04M
-22.33%2.83M
-18.70%3.19M
-40.61%3.2M
-34.30%3.81M
-General and administrative expense
-13.10%11.33M
-1.52%2.79M
-27.34%2.32M
-16.55%2.67M
-6.92%3.55M
-30.53%13.04M
-22.33%2.83M
-18.70%3.19M
-40.61%3.2M
-34.30%3.81M
Research and development costs
-41.16%10.96M
-51.75%2.17M
-45.31%2.54M
-44.74%2.53M
-24.24%3.73M
1.79%18.63M
-0.09%4.49M
21.45%4.64M
-4.18%4.58M
-5.51%4.92M
Operating profit
29.61%-22.29M
32.31%-4.96M
37.99%-4.85M
33.14%-5.21M
16.68%-7.27M
14.57%-31.66M
10.06%-7.32M
-1.11%-7.82M
23.48%-7.79M
20.69%-8.73M
Net non-operating interest income expense
-50.93%1.21M
-56.44%220K
-50.35%283K
-51.78%311K
-47.03%392K
-29.31%2.46M
-36.48%505K
-32.46%570K
-29.43%645K
-20.17%740K
Non-operating interest income
-51.41%1.24M
-57.28%223K
-51.10%289K
-52.02%321K
-47.27%405K
-29.64%2.55M
-36.80%522K
-32.61%591K
-29.73%669K
-20.74%768K
Non-operating interest expense
-64.44%32K
-82.35%3K
-71.43%6K
-58.33%10K
-53.57%13K
-37.50%90K
-45.16%17K
-36.36%21K
-36.84%24K
-33.33%28K
Other net income (expense)
99.58%-4K
102.10%20K
-1K
-41K
1,000.00%18K
-84.53%-954K
-1,320.90%-952K
97.92%-2K
Special income (charges)
--0
102.21%21K
---1K
---40K
--20K
-214.90%-951K
---951K
--0
--0
--0
-Less:Impairment of capital assets
--0
----
----
----
----
--951K
----
----
----
----
-Gain on sale of property,plant,equipment
----
----
---1K
---40K
--20K
--0
--0
--0
--0
--0
Other non- operating income (expenses)
-33.33%-4K
0.00%-1K
----
---1K
0.00%-2K
98.60%-3K
98.51%-1K
----
----
-122.22%-2K
Income before tax
30.08%-21.09M
39.29%-4.72M
37.01%-4.57M
30.89%-4.94M
14.11%-6.86M
11.57%-30.16M
-4.80%-7.77M
-1.81%-7.25M
23.91%-7.14M
21.47%-7.99M
Income tax
Net income
30.08%-21.09M
39.29%-4.72M
37.01%-4.57M
30.89%-4.94M
14.11%-6.86M
11.57%-30.16M
-4.80%-7.77M
-1.81%-7.25M
23.91%-7.14M
21.47%-7.99M
Net income continuous Operations
30.08%-21.09M
39.29%-4.72M
37.01%-4.57M
30.89%-4.94M
14.11%-6.86M
11.57%-30.16M
-4.80%-7.77M
-1.81%-7.25M
23.91%-7.14M
21.47%-7.99M
Minority interest income
Net income attributable to the parent company
30.08%-21.09M
39.29%-4.72M
37.01%-4.57M
30.89%-4.94M
14.11%-6.86M
11.57%-30.16M
-4.80%-7.77M
-1.81%-7.25M
23.91%-7.14M
21.47%-7.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.08%-21.09M
39.29%-4.72M
37.01%-4.57M
30.89%-4.94M
14.11%-6.86M
11.57%-30.16M
-4.80%-7.77M
-1.81%-7.25M
23.91%-7.14M
21.47%-7.99M
Basic earnings per share
30.36%-16.72
39.38%-3.74
37.26%-3.62
31.28%-3.91
15.63%-5.4
1.60%-24.01
-2.83%-6.17
-3.04%-5.77
8.23%-5.69
3.03%-6.4
Diluted earnings per share
30.36%-16.72
39.38%-3.74
37.26%-3.62
31.28%-3.91
15.63%-5.4
1.60%-24.01
-2.83%-6.17
-3.04%-5.77
8.23%-5.69
3.03%-6.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.61%22.29M-32.31%4.96M-37.99%4.85M-33.14%5.21M-16.68%7.27M-14.57%31.66M-10.06%7.32M1.11%7.82M-23.48%7.79M-20.69%8.73M
Selling and administrative expenses -13.10%11.33M-1.52%2.79M-27.34%2.32M-16.55%2.67M-6.92%3.55M-30.53%13.04M-22.33%2.83M-18.70%3.19M-40.61%3.2M-34.30%3.81M
-General and administrative expense -13.10%11.33M-1.52%2.79M-27.34%2.32M-16.55%2.67M-6.92%3.55M-30.53%13.04M-22.33%2.83M-18.70%3.19M-40.61%3.2M-34.30%3.81M
Research and development costs -41.16%10.96M-51.75%2.17M-45.31%2.54M-44.74%2.53M-24.24%3.73M1.79%18.63M-0.09%4.49M21.45%4.64M-4.18%4.58M-5.51%4.92M
Operating profit 29.61%-22.29M32.31%-4.96M37.99%-4.85M33.14%-5.21M16.68%-7.27M14.57%-31.66M10.06%-7.32M-1.11%-7.82M23.48%-7.79M20.69%-8.73M
Net non-operating interest income expense -50.93%1.21M-56.44%220K-50.35%283K-51.78%311K-47.03%392K-29.31%2.46M-36.48%505K-32.46%570K-29.43%645K-20.17%740K
Non-operating interest income -51.41%1.24M-57.28%223K-51.10%289K-52.02%321K-47.27%405K-29.64%2.55M-36.80%522K-32.61%591K-29.73%669K-20.74%768K
Non-operating interest expense -64.44%32K-82.35%3K-71.43%6K-58.33%10K-53.57%13K-37.50%90K-45.16%17K-36.36%21K-36.84%24K-33.33%28K
Other net income (expense) 99.58%-4K102.10%20K-1K-41K1,000.00%18K-84.53%-954K-1,320.90%-952K97.92%-2K
Special income (charges) --0102.21%21K---1K---40K--20K-214.90%-951K---951K--0--0--0
-Less:Impairment of capital assets --0------------------951K----------------
-Gain on sale of property,plant,equipment -----------1K---40K--20K--0--0--0--0--0
Other non- operating income (expenses) -33.33%-4K0.00%-1K-------1K0.00%-2K98.60%-3K98.51%-1K---------122.22%-2K
Income before tax 30.08%-21.09M39.29%-4.72M37.01%-4.57M30.89%-4.94M14.11%-6.86M11.57%-30.16M-4.80%-7.77M-1.81%-7.25M23.91%-7.14M21.47%-7.99M
Income tax
Net income 30.08%-21.09M39.29%-4.72M37.01%-4.57M30.89%-4.94M14.11%-6.86M11.57%-30.16M-4.80%-7.77M-1.81%-7.25M23.91%-7.14M21.47%-7.99M
Net income continuous Operations 30.08%-21.09M39.29%-4.72M37.01%-4.57M30.89%-4.94M14.11%-6.86M11.57%-30.16M-4.80%-7.77M-1.81%-7.25M23.91%-7.14M21.47%-7.99M
Minority interest income
Net income attributable to the parent company 30.08%-21.09M39.29%-4.72M37.01%-4.57M30.89%-4.94M14.11%-6.86M11.57%-30.16M-4.80%-7.77M-1.81%-7.25M23.91%-7.14M21.47%-7.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.08%-21.09M39.29%-4.72M37.01%-4.57M30.89%-4.94M14.11%-6.86M11.57%-30.16M-4.80%-7.77M-1.81%-7.25M23.91%-7.14M21.47%-7.99M
Basic earnings per share 30.36%-16.7239.38%-3.7437.26%-3.6231.28%-3.9115.63%-5.41.60%-24.01-2.83%-6.17-3.04%-5.778.23%-5.693.03%-6.4
Diluted earnings per share 30.36%-16.7239.38%-3.7437.26%-3.6231.28%-3.9115.63%-5.41.60%-24.01-2.83%-6.17-3.04%-5.778.23%-5.693.03%-6.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -